WANBURY
|
The Current P/S Ratio of WANBURY is 1.46.
| Share Price | ₹280.2 | Sep 05,2025 |
| Market Cap | ₹921.7 Cr | |
| Sales-TTM | ₹629.8 Cr | TTM-Consolidated Results |
| Price/Sales | 1.46x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WANBURY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹921.7 Cr] as on Sep 05,2025
(/) Sales [ ₹629.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.46x ]
Thus, for WANBURY , the investors are currently willing to pay '1.46 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WANBURY !
The chart below summarizes the trend in P/S Ratio of WANBURY over the last five years.
Historical PS (Price/Sales) ratio chart of WANBURY
PS Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.45x.
- WANBURY 's operated at median p/e ratio of 0.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 0.83x.
- WANBURY 's p/e ratio hit its five-year low in Mar2020 of 0.12x.
How does WANBURY 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WANBURY | 629.8 | 1.46 | 921.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.11 | 382,622.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 16.53 | 159,536.0 |
| CIPLA LTD | 27,811.2 | 4.51 | 125,468.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.24 | 121,162.0 |
| DR REDDYS LABORATORIES LTD | 33,519.9 | 3.16 | 105,874.0 |
| MANKIND PHARMA LTD | 12,956.2 | 8.13 | 105,315.0 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.32 | 102,047.0 |
| LUPIN LTD | 23,375.9 | 3.80 | 88,822.8 |
| AUROBINDO PHARMA LTD | 32,024.8 | 1.89 | 60,658.9 |
| ABBOTT INDIA LTD | 6,589.9 | 10.05 | 66,253.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WANBURY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.46x |
| Max industry PS | 16.53x |
| Median industry PS | 4.51x |
| Average industry PS | 6.47x |
You may also like the below Video Courses